{"id":2118,"date":"2026-07-21T10:45:30","date_gmt":"2026-07-21T08:45:30","guid":{"rendered":"https:\/\/filiere-ia.fr\/2025-sector-day\/jdlfia-2025-table-2\/"},"modified":"2026-07-22T16:03:37","modified_gmt":"2026-07-22T14:03:37","slug":"jdlfia-2025-table-2","status":"publish","type":"page","link":"https:\/\/filiere-ia.fr\/en\/2025-sector-day\/jdlfia-2025-table-2\/","title":{"rendered":"JDLFIA 2025 – Table 2"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
JFIAC 2025: Round Table 2<\/div>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

Recent Data and Rare Populations:<\/b> Recent data and rare populations: promises, challenges, and realities of automated language processing technologies<\/h1>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t
Join us at 10:10 AM at the Ministry of Economy and Finance on Thursday, September 4.<\/div>\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t<\/path><\/svg>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\tDiscover the speakers' profiles<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\tThis round table, moderated by H\u00e9l\u00e8ne Gontcharov (AI & Cancer Sector), will focus on the promises and limitations of automated language processing technologies applied to rare data.\nThrough two pilot projects led by the Sector, speakers will share their learnings, expectations, and the challenges encountered, to better understand the conditions necessary for large-scale implementation.\n\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

Moderator<\/h2>\t\t\t\t<\/div>\n\t\t
\n\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\tH\u00e9l\u00e8ne GONTCHAROV<\/span>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\tChief Financial Officer and Partnerships Director at AI & Cancer Sector<\/span>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

A graduate engineer from \u00c9cole Polytechnique and holder of a master’s degree in applied mathematics from Columbia University<\/strong>, H\u00e9l\u00e8ne has built expertise at the intersection of data, health, and innovation.<\/p>\n

After ten years in market finance, she joined Ramsay Sant\u00e9<\/strong>, where she leads investment and structuring projects, combining medical and technological challenges. Her career path has led her to engage in concrete initiatives to improve patient care pathways. <\/p>\n

Within the AI & Cancer Sector, she oversees the financing of the structure and projects while developing partnerships to support the deployment of artificial intelligence in oncology.<\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t

Speakers<\/h2>\t\t\t\t<\/div>\n\t\t
\n\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\tN\u00faria P\u00c9REZ-CULLELL\n<\/span>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\tMedical Director at Pierre Fabre<\/span>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Holder of a doctorate in pharmacy from the University of Barcelona<\/strong>, N\u00faria has been committed for over 27 years within Pierre FABRE Laboratories, where she has held various positions enabling her to bring a scientific and medical perspective in the pharmaceutical field in oncology, consumer care, rare diseases, dermatology to ensure holistic patient care. Throughout her career, she has made a significant contribution to dermatological research, with publications<\/strong> focused on chronic dermatoses and the impact of dermo-cosmetic products on patients’ quality of life. <\/p>\n

She is currently Medical Director of Pierre FABRE Laboratories,<\/strong> where she leads medical innovation with a specific goal: to understand patients’ needs<\/strong>, generate medical data in real-world conditions, and develop actions to support patients throughout their care pathway, including prevention, treatment, and post-disease support actions.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\tDr. Charlotte BERTHAUT<\/span>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\tFounder of D\u00e9pist&Vous<\/span>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Charlotte Berthaut is a physician and founder of D\u00e9pist&vous.<\/strong> Impacted by cancer in her personal and professional journey, she became a “docpreneur”<\/strong> to move from reaction to action.<\/p>\n

With D\u00e9pist&vous, she is committed to preventing earlier rather than curing, by removing barriers around cancer screening through a personalized digital platform and interactive workshops<\/strong>. Since 2020, she has combined human connection, innovation, and impact to make prevention a collective reflex. <\/p>\n

Forbes Woman 2023, Healthcare Personality of the Year, French Care Ambassador, and Regional Delegate for Women in Healthcare,<\/strong> she brings together stakeholders around an ambitious vision: to sustainably embed prevention in the culture of companies and citizens.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\tProfessor Roman ROUZIER\n<\/span>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\tGeneral Director of the Fran\u00e7ois Baclesse Center<\/span>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\tMathias BERGERON<\/span>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\tMedical Director Oncology at Johnson&Johnson Innovative Medicine<\/span>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\tJean-Baptiste ANGELOGLOU<\/span>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\tChief Executive Officer at OSPI<\/span>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

After initial training as a lawyer<\/strong>, Jean-Baptiste Angeloglou worked for 9 years at IMS Health<\/strong>, then as Commercial Director at IQVIA<\/strong>.<\/p>\n

Convinced that improving hospital care requires leveraging health data, Jean-Baptiste joined Ospi at the end of 2021 as CEO<\/strong> with one objective: to help French healthcare facilities exploit the potential of the data at their disposal while protecting it to ensure quality of care and patient management.<\/p>\n

Driven by commercial challenges and truly passionate about the healthcare sector, Jean-Baptiste does everything possible to ensure that Ospi continues to improve the daily operations of healthcare facilities<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\tG\u00e9ry Pruvost<\/span>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\tHead of Clinical Research Partnerships at Lifen<\/span>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

JFIAC 2025: Round Table 2 Recent Data and Rare Populations: Recent data and rare populations: promises, challenges, and realities of automated language processing technologies Join us at 10:10 AM at the Ministry of Economy and Finance on Thursday, September 4. Discover the speakers’ profiles This round table, moderated by H\u00e9l\u00e8ne Gontcharov (AI & Cancer Sector), […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":2111,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"class_list":["post-2118","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/filiere-ia.fr\/en\/wp-json\/wp\/v2\/pages\/2118","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/filiere-ia.fr\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/filiere-ia.fr\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/filiere-ia.fr\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/filiere-ia.fr\/en\/wp-json\/wp\/v2\/comments?post=2118"}],"version-history":[{"count":2,"href":"https:\/\/filiere-ia.fr\/en\/wp-json\/wp\/v2\/pages\/2118\/revisions"}],"predecessor-version":[{"id":2260,"href":"https:\/\/filiere-ia.fr\/en\/wp-json\/wp\/v2\/pages\/2118\/revisions\/2260"}],"up":[{"embeddable":true,"href":"https:\/\/filiere-ia.fr\/en\/wp-json\/wp\/v2\/pages\/2111"}],"wp:attachment":[{"href":"https:\/\/filiere-ia.fr\/en\/wp-json\/wp\/v2\/media?parent=2118"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}